11th Annual meeting of the EBMT pp 40-40 | Cite as
Bone Marrow Transplantation Versus Chemotherapy alone for Acute Nonlymphoblastic Leukemia
Chapter
Abstract
The question whether allogeneic bone marrow transplantation (BMT) carries greater advantage for patients with ANLL as compared to chemotherapy (CT) alone has been and is still debated intensively (1,2). The issue has been further complicated by recent results with autologous BMT (3). In this contribution a retrospective analysis from our clinical experience is presented.
Keywords
Clinical Experience Retrospective Analysis Bone Marrow Transplantation Recent Result International Society
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Gale, R.P., Champlin, R.E.-In Gale R.P.(ed) “Recent Advances in Bone Marrow Transplantation”; Liss,N.Y., 1983.Google Scholar
- 2.Begg, C.B. et al J. Clin. Oncol. 2: 369–378, 1984.PubMedGoogle Scholar
- 3.Burnett, A.K. et al–Lancet 2: 1068–1070, 1984.PubMedCrossRefGoogle Scholar
- 4.Rai, K.R. etal–Lancet 58: 1203–1212, 1981.Google Scholar
- 5.Vitale, V., etal–Brit.J.Haematol. 55: 547–554, 1983.CrossRefGoogle Scholar
- 6.Carella, A.M. et al.-Leukemia Res.,in the press.Google Scholar
- 7.Santer, Chr. et al.-Lancet 1: 379–382, 1984.Google Scholar
- 8.Champlin, R. et al.-Lancet 1: 894–895, 1984.PubMedCrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media New York 1985